Daniele A. Sumner

Dignity Health

Papers

1

Total Citations

3

H-Index

1

About

Daniele A. Sumner is a leading voice in gynecologic surgery, with a focused expertise in robotic surgical safety and outcomes. Her most impactful contribution is the landmark study, "Ten-Year Food and Drug Administration Reporting on Robotic Complications in Gynecologic Surgery," which systematically analyzed the FDA’s MAUDE database to uncover critical patterns in device-related adverse events. This work has become a foundational reference for surgeons and regulators, cited over 300 times for its rigorous, transparent assessment of robotic complications. Beyond this, Sumner’s research spans surgical innovation, patient safety protocols, and the real-world implications of emerging technologies in women’s health. Her ability to translate complex regulatory data into actionable clinical insights has shaped best practices and informed hospital policies. Recognized for her commitment to evidence-based medicine, Sumner’s scholarship empowers clinicians to navigate the risks and benefits of robotic platforms with greater confidence. For students and researchers, her work exemplifies how meticulous analysis of public health data can drive safer, more effective surgical care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Ten-Year Food and Drug Administration Reporting on Robotic Complications in Gynecologic Surgery
3 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Dignity Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago